Intracellular clusterin induces G2-M phase arrest and cell death in PC-3 prostate cancer cells

Cancer Research

Volumn 64, Issue 17, 2004, Pages 6174-6182

  Scaltriti, Maurizio ^a,b   Santamaria, Anna ^a   Paciucci, Rosanna ^a   Bettuzzi, Saverio ^b  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^b UNIVERSITY OF PARMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CLUSTERIN;

APOPTOSIS; ARTICLE; CANCER CELL; CELL CYCLE G2 PHASE; CELL DEATH; CELL MATURATION; CELL PROLIFERATION; COMPLEX FORMATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; MITOSIS INDEX; MOLECULAR CLONING; NUCLEAR LOCALIZATION SIGNAL; PRIORITY JOURNAL; PROSTATE CANCER; PROTEIN LOCALIZATION; PROTEIN SECRETION;

AMINO ACID SEQUENCE; APOPTOSIS; BASE SEQUENCE; CELL CYCLE; CELL DIVISION; CELL LINE, TUMOR; CLUSTERIN; G2 PHASE; GENETIC VECTORS; GLYCOPROTEINS; HUMANS; MALE; MITOSIS; MOLECULAR CHAPERONES; MOLECULAR SEQUENCE DATA; PEPTIDES; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; SUBCELLULAR FRACTIONS; TRANSFECTION;

EID: 4344616635     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-04-0920     Document Type: Article

References (44)

1. Crawford ED. Epidemiology of prostate cancer. Urology 2003;62:3-12.
2. Visakorpi T. The molecular genetics of prostate cancer. Urology 2003;62:3-10.
3. Guseva NV, Taghiyev AF, Rokhlin OW, Cohen MB. Death receptor-induced cell death in prostate cancer. J Cell Biochem 2004;91:70-99.
4. Bettuzzi S, Hjipakka RA, Gilna P, Liao SA. Identification of an androgen-repressed mRNA in rat ventral prostate as coding for sulphated glycoprotein 2 by cDNA cloning and sequence analysis. Biochem J 1989;257:293-6.
5. Lakins J, Bennett SAL, Chen JH, et al. Clusterin biogenesis is altered during apoptosis in the regressing rat ventral prostate. J Biol Chem 1998;273:27887-95.
6. Astancolle S, Guidetti G, Pinna C, Corti A, Bettuzzi S. Increased levels of clusterin (SGP-2) mRNA and protein accompany rat ventral prostate involution following finasteride treatment. J Endocrinol 2000;167:197-204.
7. Crescioli C, Ferruzzi P, Caporali A, et al. Inhibition of spontaneous and androgen-induced prostate growth by a nonhypercalcemic calcitriol analog. Endocrinology 2003;144:3046-57.
8. Grima J, Zwain I, Lockshin RA, Bardin CW, Cheng CY. Diverse secretory patterns of clusterin by epididymis and prostate/seminal vesicles undergoing cell regression after orchiectomy. Endocrinology 1990;126:2989-97.
9. Buttyan R, Olsson CA, Pintar J, et al. Induction of the TRPM-2 gene in cells undergoing programmed death. Mol Cell Biol 1989;9:3473-81.
10. Bettuzzi S, Strocchi P, Marinelli M, et al. Gene relaxation and aging: changes in the abundance of rat ventral prostate SGP-2 (clusterin) and ornithine decarboxylase mRNAs. FEBS Lett 1994;348:255-8.
11. Michel D, Moyse E, Trembleau A, Jourdan F, Brun G. Clusterin/ApoJ expression is associated with neuronal apoptosis in the olfactory mucosa of the adult mouse. J Cell Sci 1997;110:1635-45.
12. Michel D, Chatelain G, North S, Brun G. Stress-induced transcription of the clusterin/apoJ gene. Biochem J 1997:328:45-50.
13. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol 2002;34:427-31.
14. Bettuzzi S, Davalli P, Astancolle S, et al. Tumor progression is accompanied by significant changes in the levels of expression of polyamine metabolism regulatory genes and clusterin (sulfated glycoprotein 2) in human prostate cancer specimens. Cancer Res 2000;60:28-34.
15. Scaltriti M, Brausi M, Amorosi A, et al. Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer. Int J Cancer 2004;108: 23-30.
16. Steinberg J, Oyasu R, Lang S, et al. Intracellular levels of SGP-2 (Clusterin) correlate with tumor grade in prostate cancer. Clin Cancer Res 1997;3:1707-11.
17. July LV, Akbari M, Zellweger T, et al. Clusterin expression is significantly enhanced in prostate cancer cells following androgen withdrawal therapy. Prostate 2002;50: 179-88.
18. Leskov KS, Klokov DY, Li J, Kinsella TJ, Boothman DA. Synthesis and functional analyses of nuclear clusterin, a cell death protein. J Biol Chem 2003;278:11590-600.
19. O'Sullivan J, Whyte L, Drake J, Tenniswood M. Alterations in the post-translational modification and intracellular trafficking of clusterin in MCF-7 cells during apoptosis. Cell Death Differ 2003;10:914-27.
20. Reddy KB, Jin G, Karode MC, Harmony JAK, Howe PH. Transforming growth factor beta (TGF beta)-induced nuclear localization of apolipoprotein J/clusterin in epithelial cells. Biochemistry 1996;35:6157-63.
21. Yang CR, Leskov K, Hosley EK, et al. Nuclear clusterin/XIP8, an x-ray-induced Ku70-binding protein that signals cell death. Proc Nat Acad Sci USA 2000;97:5907-12.
22. Wong P, Ulyanova T, Organisciak DT, et al. Expression of multiple forms of clusterin during light-induced retinal degeneration. Curr Eye Res 2001;23:157-65.
23. Pucci S, Bonanno E, Pichiorri F, Angeloni C, Spagnoli LG. Modulation of different clusterin isoforms in human colon tumorigenesis. Oncogene 2004;23:2298-304.
24. Criswell T, Klokov D, Beman M, Lavik JP, Boothman DA. Repression of IR-inducible clusterin expression by the p53 tumor suppressor protein. Cancer Biol Ther 2003;2:372-80.
25. Debure L, Vayssiere JL, Rincheval V, et al. Intracellular clusterin causes juxtanuclear aggregate formation and mitochondrial alteration. J Cell Sci 2003;116:3109-21.
26. Kaighn ME, Narayan KS, Ohnuki Y, Lechner JF, Jones LW. Establishment and characterization of a human prostatic carcinoma cell line (PC-3). Investig Urol 1979;17:16-33.
27. Freudenreich CH, Kreuzer KN. Mutational analysis of a type II topoisomerase cleavage site: distinct requirements for enzyme and inhibitors. EMBO J 1993;12: 2085-97.
28. Capranico G, Palumbo M, Tinelli S, Zunino F. Unique sequence specificity of topoisomerase II DNA cleavage stimulation and DNA binding mode of streptonigrin. J Biol Chem 1994;269:25004-9.
29. Burden DA, Kingma PS, Froelich-Ammon SJ, et al. Topoisomerase II.etoposide interactions direct the formation of drug-induced enzyme-DNA cleavage complexes. J Biol Chem 1996;271:29238-44.
30. Porter LA, Donoghue DJ. Cyclin B1 and CDK1: nuclear localization and upstream regulators. Prog Cell Cycle Res 2003;5:335-47.
31. Wu AJ, Park II, Zhaung L, Lee C. Response to a lethal dose of heat shock by a transient up-regulation of clusterin expression followed by down-regulation and apoptosis in prostate and bladder cancer cells. Prostate 2002;53:277-85.
32. Sensibar JA, Sutkowski DM, Raffo A, et al. Prevention of cell death induced by tumor necrosis factor alpha in LNCaP cells by overexpression of sulfated glycoprotein-2 (clusterin). Cancer Res 1995;55:2431-7.
33. Miyake H, Nelson C, Rennie PS, Gleave ME. Testosterone-repressed prostate message-2 is an antiapoptotic gene involved in progression to androgen independence in prostate cancer. Cancer Res 2000;60:170-6.
34. Humphreys DT, Carver JA, Easterbrook-Smith SB, Wilson MR. Clusterin has chaperone-like activity similar to that of small heat shock proteins. J Biol Chem 1999; 274:6875-81.
35. Bartl MM, Luckenbach T, Bergner O, Ullrich O, Koch-Brandt C. Multiple receptors mediate apoJ-dependent clearance of cellular debris into nonprofessional phagocytes. Exp Cell Res 2001;271:130-41.
36. Bettuzzi S, Scaltriti M, Caporali A, et al. Successful prediction of prostate cancer recurrence by gene profiling in combination with clinical data: A 5-year follow-up study. Cancer Res 2003;63:3469-72.
37. Bettuzzi S, Scorcioni F, Astancolle S, et al. Clusterin (SGP-2) transient overexpression decreases proliferation rate of SV40-immortalized human prostate epithelial cells by slowing down cell cycle progression. Oncogene 2002;21:4328-34.
38. Furuya Y, Ohta S, Ito H. Apoptosis of androgen-independent mammary and prostate cell lines induced by topoisomerase inhibitors: Common pathway of gene regulation. Anticancer Res 1997;17:2089-93.
39. Howell SB. Resistance to apoptosis in prostate cancer cells. Mol Urol 2000;4:225-9.
40. Shaffer DR, Scher HI. Prostate cancer: a dynamic illness with shifting targets. Lancet Oncol 2003;4:407-14.
41. Trougakos IP, So A, Jansen B, Gleave ME, Gonos ES. Silencing expression of the clusterin/apolipoprotein j gene in human cancer cells using small interfering RNA induces spontaneous apoptosis, reduced growth ability, and cell sensitization to genotoxic and oxidative stress. Cancer Res 2004;64:1834-42.
42. Roninson IB, Broude EV, Chang BD. If not apoptosis, then what? Treatment-induced senescence and mitotic catastrophe in tumor cells. Drug Resist Updat 2001;4:303-13.
43. Wuarin J, Buck V, Nurse P, Millar JB. Stable association of mitotic cyclin B/Cdc2 to replication origins prevents endoreduplication. Cell 2002;111:41-31.
44. Castedo M, Perfettini JL, Roumier T, Kroemer G. Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe. Cell Death Differ 2002;9:1287-93.